| Phase I Study of Continuous Administration of Salvianolic Acid A Tablet | Randomized, Double-blind, Placebo-controlled, Continuous Dosing, Single-center, Evaluation of Safety, Tolerability, and Pharmacokinetic Properties of Salvianolic Acid A Tablets in Healthy Volunteers | NCT03908242 |
| Effect of Food on Pharmacokinetics of Salvianolic Acid A in Healthy Subjects | A Phase I, Single Centre, Randomized, Open-Label, Three-Period Crossover Study to Investigate the Effect of Food on Pharmacokinetics of Salvianolic Acid A in Healthy Subjects | NCT03791463 |
| Efficacy and Safety of Salvianolic Acid on AIS | Efficacy and Safety of Salvianolic Acid on Acute Ischemic Stroke | NCT04931628 |
| Salvianolic acid A inhibits the activation and aggregation of platelets in patients with acute coronary syndrome | Salvianolic acid A inhibits the activation and aggregation of platelets in patients with acute coronary syndrome | ITMCTR2024000668 |
| Salvianolic acid A for cerebral small vessel disease cognitive impairment | Salvianolic acid A for cerebral small vessel disease cognitive impairment —— A Single-center, Prospective, Single-arm, Clinical Trial | ChiCTR2500103456 |
| Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets | Randomized, Double-blind, Placebo-controlled, Single-dose Escalation, Evaluation of Safety, Tolerability, and Pharmacokinetic Properties of Salvianolic Acid A Tablets in Healthy Volunteers | NCT03791125 |
